News, visuals and downloads straight from Lysando
©2023 Lysando
-
All rights reserved
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Read Article
Artilysin® – A Groundbreaking „Green Pharma“ Solution
Read Article on
Read Article on
Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
Read Article on
Read Article on
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Read Article on
Read Article on
Artilysin®: Promising approach against Acinetobacter baumannii infected wounds
Read Article on
Read Article on
Artilysin®: Fearless Into the Post-antibiotic Era
Read Article on
Read Article on
Lysando AG and Amicogen Inc. Sign General Development Agreement
Read Article on
Read Article on
Dr. Fabian Geldmacher is Director Strategy & Business Development
Read Article on
Read Article on
Wilhelm von Haller is Chief Financial Officer of Lysando AG
Read Article on
Read Article on
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
Read Article on
Read Article on
AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections
Read Article on
AMICOGEN Inc. and Lysando AG bring partnership to the next level with ownership participations in each other’s companies
Read Article on
Read Article on
Lysando AG and AMICOGEN Inc. forge a strategic partnership
Read Article on
Read Article on
Alternative to antibiotics
Read Article on
The search for new antibiotics
Read Article on
What’s next after antibiotics?
Read Article on
The medical sensation
Read Article on